secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001437749-25-033877
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key receives Nasdaq extension to May 2026 to regain $1 bid price compliance
-------------------------------------------------------------------------------

- Nasdaq granted BIO-key an additional 180-day period, until May 4, 2026, to meet the $1.00 minimum bid price rule.
- The extension follows a prior notice from May 9, 2025, and is contingent on meeting all other listing requirements.
- The company intends to effect a reverse stock split if necessary to cure the bid price deficiency.
- Failure to comply by May 4, 2026, will result in Nasdaq delisting; company may appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774925033877/0001437749-25-033877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774925033877/bkyi20251107_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-033877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer